Skip to main content
Download PDF

Evaluation of a new Q-switched Nd:YAG laser on premacular hemorrhage

BMC Ophthalmology volume 23, Article number: 146 (2023) Cite this article

Abstract

Background

Premacular hemorrhage is among the causes of sudden deterioration of visual acuity. This study aimed to investigate the therapeutic outcomes of a new Q-switched Nd:YAG laser on premacular hemorrhage.

Methods

Retrospective, case series study of 16 eyes from 16 patients diagnosed with premacular hemorrhage, including 3 cases of Valsalva retinopathy, 8 cases of retinal macroaneurysm, 3 cases of diabetic retinopathy, 1 case of trauma-related hemorrhage and 1 case with leukemia. A 1064nm Q-switched Nd:YAG laser was performed to puncture the posterior hyaloid and inner limiting membrane to drain the hemorrhage.

Results

The success rate of 16 patients with premacular hemorrhage drainage was 100% in this study. Improved visual acuity was observed in each patient.

Conclusions

In this case series of 16 patients, the new Q-switched Nd:YAG laser was successful in draining premacular hemorrhage with no serious complications.

Peer Review reports

Background

Premacular hemorrhage is the accumulation of hemorrhage in the vitreo-retinal interface, located in front of the macular [1,2,3]. It generally occurs in diabetic retinopathy [4, 5], ruptured retinal macroaneurysm [6,7,8,9], Terson’s syndrome[10], or ruptured retinal vessels after distant trauma or physical sport (Valsalva) [11, 12]. Premacular hemorrhage in small amounts may be managed conservatively [12]. Dense premacular hemorrhage or combined with proliferation usually needs surgical intervention [13,14,15]. The use of Nd:YAG laser has been reported in the drainage of premacular hemorrhage by puncturing the anterior surface of the hemorrhagic cyst [16,17,18].

The Q-switched Nd:YAG laser produces near-infrared radiation at 1064 nm, with each pulse between 2 and 14 nanoseconds [19]. It is clinically used to disintegrate hemorrhagic cysts by ionization, which substitutes surgical interventions. Compared with mode-locked Nd:YAG laser, Q-switched Nd:YAG laser has the advantages of lower focused spot irradiance and less damage to the retina [20]. Treatment of premacular hemorrhage with Q-switched Nd:YAG laser has been reported in several studies [5, 16]. Despite the above advantages, traditional Q-Switched Nd:YAG has a risk of chorioretinal injury when the focus is close to the retina (1.5-3 mm) [21]. The appearance of non-clearing vitreous hemorrhage and progress into retinal detachment were uncommon but require further vitrectomy [22]. A complication with macular hole was reported in a long-term follow-up study [23]. Ultra Q reflex (Ellex Medical Pty Ltd, Australia), a new Q-switched Nd:YAG laser, has been applied in the treatment of floaters in the posterior vitreous in recent years. Its laser cavity was capable of producing a 4 nanosecond Ultra Gaussian pulse at a high peak energy and achieves optical breakdown at a low energy level. Investigating its therapeutic application on premacular hemorrhage could be valuable.

The purpose of this study was to evaluate the therapeutic effect of this new Q-switched Nd:YAG laser on premacular hemorrhage. We included premacular hemorrhage cases with diabetic retinopathy, ruptured retinal macroaneurysm, Valsalva retinopathy and et al in this study.

Methods

This study has been approved by the Institutional Review Board of the Second Affiliated Hospital, School of Medicine, Zhejiang University in Hangzhou, China. All patients provided written informed consent.

This retrospective, case series study enrolled premacular hemorrhage patients between May 2017 and January 2023 at the Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University. The inclusion criteria include (1) hemorrhage accumulated in front of macular, diagnosed as premacular hemorrhage; (2) the new Q-switched Nd:YAG laser (Ultra Q Reflex, Ellex Medical Pty Ltd, Australia) was applied for hemorrhage drainage within one week. Patients with a history of ocular surgery or infection were excluded.

Premacular hemorrhage was diagnosed based on optical coherence tomography (OCT) (Stratus OCT, Carl Zeiss Meditec, USA; Spectralis OCT, Heidelberg, Germany), fundus photographs (Daytona, Optos PLC, Dunfermline, United Kingdom), fluorescein angiography (FFA) (Heidelberg Engineering, Heidelberg, Germany) and posterior segment examination by experienced ophthalmologists. Best-corrected visual acuity (BCVA) was examined during follow-up and converted to logMAR equivalent [24, 25]. The new 1064 nm Q-switched Nd:YAG laser was performed to create an opening at the highest anterior surface of the hemorrhagic cyst, while avoiding damage to macular or adjacent vessels. Laser exposures started with an energy of 3 mJ and gradually increases until successful drainage. Several shots were tried per energy stage by the same experienced ophthalmologist. Once a successful puncture was achieved, the patient was asked to remain in a sitting position for two hours to drain the hemorrhage by gravity. All patients were asked to follow up within 1 week. Successful draining was the primary outcome of this study, considered as the disappearance of hemorrhage from the fovea area at 1-week follow-up [6].

Statistical analyses were performed with SPSS version 26.0 (SPSS, Inc., Chicago, IL, USA). The pre-and post-laser BCVA values were converted to logMAR equivalent for statistical analysis and compared by compared t-test. P < 0.05 was considered statistically significant.

Results

Sixteen eyes from 16 patients (6 males and 10 females) of premacular hemorrhage were enrolled in this study (Table 1). Three of them were diagnosed with diabetic retinopathy, 8 with retinal macroaneurysm, 1 with trauma-related hemorrhage, 3 with Valsalva retinopathy, and 1 with leukemia. The follow-up period ranged from 1 week to 2 years (median 2 months). The mean size of the hemorrhage pre-treatment was 3.81 disc diameters, which was measured based on fundus photographs. The BCVA ranged from counting fingers at 0.5 m to counting fingers at 1 m.

Table 1 Summary of patients’ characteristics
Full size table

All patients underwent 1 to 6 (mean 2.50) laser shots, with the energy ranging from 3.0 to 3.8 mJ (mean 3.39 mJ per shot). The hemorrhage drainage rate was 100% in 16 patients. The mean BCVA was significantly improved at 1 week and remained stable during follow-up (range from 20/100 to 20/20). The characteristics of the patients were summarized in Table 1. Statistical analysis of BCVA before and 1 week after the treatment was presented in Table 2.

Table 2 The statistical analysis of visual acuity before and 1 week after treatment
Full size table

Fourteen of 16 patients had residual hemorrhage at the lower edge of the hemorrhagic cyst for a short term after laser. Peripheral hemorrhage was found in Case 9 of diabetic retinopathy. Vitreo-retinal traction exacerbated along with the spontaneous absorption of the hemorrhage. Partial subretinal hemorrhage was observed in Case 4 of retinal macroaneurysm at 4 months follow-up. Hard intraretinal exudation was observed at 10 months in this patient. Complications, including macular hole, retinal detachment, or hemorrhage in the retina or choroid, were not found in this study. None of these patients underwent additional surgical intervention during the follow-up.

Case presentation

Case 3 was a 71-year-old female diagnosed with retinal macroaneurysm by FFA. OCT scanning revealed pre-retinal hemorrhage and subretinal fluid. After the drainage of premacular hemorrhage with the new Q-switch Nd:YAG laser, we also performed 523 nm laser photocoagulation to the macroaneurysm. Disruption of the neuroretina structure of the fovea was observed 1 week after treatment (Fig. 1).

Fig. 1
figure 1

Case 3: a female with ruptured retinal macroaneurysm. (A): FFA (A1), fundus photographs (A2), and vertical scanning OCT pre-laser (A3). In the arterial stage, blocked fluorescence was observed due to the premacular hemorrhage. The retinal macroaneurysm showed a focal nodular hyperfluorescence (white arrow). Subretinal fluid was observed (blue arrow). (B): fundus photographs (B1) and OCT (B2) 1 month after treatment. High reflection was observed at the site of the macroaneurysm (yellow arrow)

Full size image

Case 9 was a 53-year-old male with diabetic retinopathy. Fundus photographs revealed an accumulation of hemorrhage in the macular area and around the optic disc. Hemorrhage beneath ILM was confirmed by OCT scanning. After successful drainage of premacular hemorrhage, the development of proliferation close to the superior temporal branch artery was noted during the follow-up at 2 months (Fig. 2).

Fig. 2
figure 2

Case 9: a 53-year-old male with diabetic retinopathy. Examinations were performed 1 day before (A1, A2, A3, B1, and B2), 1 week after (A4 and B3), 1 (A5) and 2 months (A6 and B4) after the treatment. The optic disc was around by dense hemorrhage (white arrow) (A1, A3). FFA showed no perfusion area and neovascularization (A2) The proliferation got severe secondary to residual preretinal hemorrhage (black arrow) (A4, A5, and A6). The detached posterior hyaloid presented as an elliptic boundary (blue arrow). The dense preretinal hemorrhage was shown in horizontal and vertical scan lines (star) (B1 and B2). The fibrosis proliferation got serious during follow-up (B3 and B4)

Full size image

Case 13 was a 28-year-old female diagnosed with Valsalva retinopathy. A vitreous separation with a sizable hole in the ILM was observed with only 2 shots of the new Q-switch Nd:YAG laser (Fig. 3).

Fig. 3
figure 3

Case 13: a case with Valsalva retinopathy. Examinations were performed 1 day before (A1 and B1), the day of the treatment (A2), and 2 years follow-up (A3 and B2). A vitreous separation and rupture of the ILM were observed (B2, white arrow)

Full size image

Case 15 was a 33-year-old female diagnosed with trauma-related premacular hemorrhage. No serious complications were observed after the treatment during the follow-up (Fig. 4).

Fig. 4
figure 4

Case 15: a case with trauma-related hemorrhage. Examinations were performed 1 day before (A and D), the day of the treatment (B and E), and 1 week after the treatment (C). The boundary between thin and dense hemorrhage due to gravity was observed (D, white arrow). The puncture opening in the ILM and the normal retinal structure beneath (E, white arrow)

Full size image

Discussion

Previous studies of preretinal hemorrhage treated with traditional Nd:YAG have demonstrated varying effective rates in hemorrhage drainage and incidence of complications. Our study found that the new Q-switched Nd:YAG laser has a high rate of premacular hemorrhage drainage without energy-related retinal or choroidal damage.

Premacular hemorrhage usually presents as a cyst of hemorrhage in front of the macular, resulting in impairs of central vision. The rupture of retinal macroaneurysm is the primary cause of premacular hemorrhage, usually presenting as dense blood accumulation [8, 26, 27]. Visual acuity may be worse when combined with intraretinal and subretinal hemorrhage, or macular edema and exudation [6, 7, 26, 28]. This study enrolled 8 cases with ruptured retinal macroaneurysm. Drainage of the premacular hemorrhage was successful in all patients. However, there was one case with subretinal hemorrhage in SD-OCT, suggesting a poor visual outcome. Premacular hemorrhage caused by Valsalva retinopathy is usually accompanied by a history of elevated vascular pressure [11], which usually results in a better prognosis and fewer complications than patients with other causes [18, 22, 23]. Patients with Valsalva retinopathy and trauma-related hemorrhage in our study did not have noticeable complications after treatment. In proliferative diabetic retinopathy, the premacular hemorrhage usually presents dense and is accompanied by vitreous hemorrhage [16]. Retinal neovascularization, macular edema, extensive rebleeding, and even retinal detachment are the primary causes of loss of visual acuity due to the pathology of proliferative diabetic retinopathy, which necessitates vitrectomy or intraocular injection of anti-vascular endothelial growth factor [16, 29]. Even if the premacular hemorrhage is successfully drained, the visual acuity is partial. The structure of the fovea and the function of photoreceptors are key factors in determining vision [30]. After successful drainage, the macular structure could be examined by OCT scanning. The necessity of surgical intervention can be evaluated according to the follow-up outcomes and may help to avoid unnecessary procedures. There are few reports of pre-macular hemorrhage in leukemia patients [27]. We report a premacular hemorrhage case with leukemia, who obtained a satisfactory result after treatment.

Previous studies have investigated the effectiveness of conservative observation, membranotomy, and vitrectomy for premacular hemorrhage [12,13,14,15]. Instantly removing the hemorrhage and potential epiretinal membranes by vitrectomy may lead to tractional retinal detachment. However, it might increase the risk of infection due to the incision of the eyeball, destroy the natural support and barrier functions of the vitreous body, and increase the risk of complications by postoperative glucocorticoid usage. Compared with vitrectomy, locked and traditional Q-switched Nd:YAG laser has the advantage of preserving the integrity of the eyeball which avoids possible surgical complications, shortens the treatment process, and lowers the dose of glucocorticoids [18, 22]. However, their optical design makes it impossible to accurately target the laser burst point close to the retina. Rebleeding, which implies damage to the retina or choroid, was reported in cases of diabetic retinopathy, Valsalva retinopathy, and Eales’ disease after laser [14, 22, 23, 31]. An epiretinal membrane may also occur after laser irradiation on the posterior hyaloid [32]. In this study, a new Q-switched Nd:YAG laser, with continuously variable laser energy and optimized visualization, achieves low processing energy and ensures accurate laser focus. With this laser instrument, chorioretinal injury and rebleeding were prevented during the procedure of puncturing the hemorrhagic cyst at its highest anterior surface. Therefore, this new Q-switched Nd:YAG laser can be a safe therapeutic option, except in those cases with severe retinal traction, which usually requires surgical intervention.

Unsuccessful hemorrhage drainage and non-clearing vitreous hemorrhage are the main factors affecting the success rate of Nd:YAG laser treatment for premacular hemorrhage. In our study, there were 40 laser points in 16 patients with an average energy of 3.39 mJ, which ensured a 100% drainage rate with the energy far lower than in previous reports [22, 23]. Dense preretinal hemorrhage was observed with slower drainage by the procedure of puncturing the hemorrhagic cyst at its highest anterior surface fundus photographs and OCT. Hemorrhage draining into the vitreous was even visible 1 month after treatment (Fig. 2). We speculate that the success rate might relate to the density of hemorrhage. Undoubtedly, larger puncture size contributed to successful drainage. In this study, OCT scanning revealed that the puncture opening’s width was usually 1–2 times the thickness of the retina (Fig. 3). More laser spots and higher laser energy are required for patients with a thicker membrane of the anterior cyst surface. Increased density of the vitreous cortex, aggregated collagen fibers, and morphological changes of hyalocytes were usually observed in diabetic retinopathy patients [33]. Fibrovascular neovascularization on the retinal surface and adhered to ILM was also observed in diabetic retinopathy with preretinal hemorrhage [34]. The diabetic retinopathy cases involved in this study (cases 9 and 10) exhibited a similar diameter of the premacular hemorrhage as other cases but required the maximum amount of laser energy to achieve successful drainage. The successful puncture energies of these two patients are 3.6 and 3.8 mJ respectively, which effectively prevented tissue damage caused by high laser energy.

There are several limitations to this study. The follow-up period was relatively short and the long-term complications need further observation. We only observed cases of premacular hemorrhage in retinal microaneurysm, Valsalva retinopathy, diabetic retinopathy, trauma-related, and leukemia cases. The therapeutic effect on premacular hemorrhage with other causes needs to be further explored. In addition, a prospective study with long-term follow-up would better investigate the effectiveness and safety of this new Q-switched Nd-YAG laser in the treatment of premacular hemorrhage in the future.

Conclusions

In this case series of 16 patients, the new Q-switched Nd:YAG laser was successful in draining premacular hemorrhage with no serious complications.

Data Availability

The datasets used and analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

ILM:

Internal limiting membrane

OCT:

Optical coherence tomography

BCVA:

Best-corrected visual acuity

FFA:

fluorescein angiography

References

  1. Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Surv Ophthalmol. 1997;42(1):3–39.

    Article  CAS  PubMed  Google Scholar 

  2. Kitagawa Y, Shimada H, Kawamura A, Kaneko H, Tanaka K, Nakashizuka H. Differentiation of premacular hemorrhages with niveau formation. Int J Ophthalmol. 2022;15(12):2037–40.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kishi S, Shimizu K. Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy. Ophthalmology. 1993;100(2):225–9.

    Article  CAS  PubMed  Google Scholar 

  4. Karagiannis D, Kontadakis GA, Flanagan D. ND:YAG laser for preretinal hemorrhage in diabetic retinopathy. Am J Ophthalmol Case Rep. 2018;10:8–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ezra E, Dowler JGF, Burgess F, Sehmi K, Hamilton PAM. Identifying Maculopathy after Neodymium:YAG Membranotomy for dense Diabetic Premacular Hemorrhage. Ophthalmology. 1996;103(10):1568–74.

    Article  CAS  PubMed  Google Scholar 

  6. Iijima H, Satoh S, Tsukahara S. Nd:YAG laser photodisruption for preretinal hemorrhage due to retinal macroaneurysm. Retina. 1998;18(5):430–4.

    Article  CAS  PubMed  Google Scholar 

  7. Townsend-Pico WA, Meyers SM, Lewis H. Indocyanine green angiography in the diagnosis of retinal arterial macroaneurysms associated with submacular and preretinal hemorrhages: a case series. Am J Ophthalmol. 2000;129(1):33–7.

    Article  CAS  PubMed  Google Scholar 

  8. Zhao P, Hayashi H, Oshima K, Nakagawa N, Ohsato M. Vitrectomy for macular hemorrhage associated with retinal arterial macroaneurysm. Ophthalmology. 2000;107(3):613–7.

    Article  CAS  PubMed  Google Scholar 

  9. Doi S, Kimura S, Morizane Y, Hosokawa MM, Shiode Y, Hirano M, Toshima S, Takahashi K, Hosogi M, Fujiwara A, et al. Adverse effect of Macular Intraretinal Hemorrhage on the prognosis of Submacular Hemorrhage due to retinal arterial macroaneurysm rupture. Retina. 2020;40(5):989–97.

    Article  CAS  PubMed  Google Scholar 

  10. Bauerle J, Gross NJ, Egger K, Neubauer J, Niesen WD, Buttler KJ, Lagreze WA, Reinhard M. Terson’s syndrome: diagnostic comparison of ocular sonography and CT. J Neuroimaging. 2016;26(2):247–52.

    Article  PubMed  Google Scholar 

  11. Duane TD. Valsalva Hemorrhagic Retinopathy. Am J Ophthalmol. 1973;75(4):637–42.

    Article  CAS  PubMed  Google Scholar 

  12. Garcia Fernandez M, Navarro JC, Castano CG. Long-term evolution of Valsalva retinopathy: a case series. J Med Case Rep. 2012;6:346.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wu TT, Kung YH, Lin CS. Non-vitrectomizing vitreous surgery and adjuvant intravitreal tissue plasminogen activator for non-recent massive premacular hemorrhage. J Chin Med Assoc. 2011;74(12):574–8.

    Article  CAS  PubMed  Google Scholar 

  14. Kwok AKH, Lai TYY, Chan NR. Epiretinal membrane formation with internal limiting membrane wrinkling after nd:YAG laser membranotomy in valsalva retinopathy. Am J Ophthalmol. 2003;136(4):763–6.

    Article  PubMed  Google Scholar 

  15. O’Hanley GP, Canny CLB. Diabetic dense Premacular Hemorrhage. Ophthalmology. 1985;92(4):507–11.

    Article  PubMed  Google Scholar 

  16. Raymond LA. Neodymium:YAG laser treatment for hemorrhages under the Internal limiting membrane and posterior hyaloid face in the Macula. Ophthalmology. 1995;102(3):406–11.

    Article  CAS  PubMed  Google Scholar 

  17. Hazem HA, Shazly TA. Evaluation of pulsed nd:YAG laser posterior hyaloidotomy as an emergency treatment for blinding premacular subhyaloid hemorrhage. Open Access Emerg Med. 2011;3:33–7.

    PubMed  PubMed Central  Google Scholar 

  18. Durukan AH, Kerimoglu H, Erdurman C, Demirel A, Karagul S. Long-term results of nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy. Eye. 2008;22(2):214–8.

    Article  CAS  PubMed  Google Scholar 

  19. Mainster MA, Ho PC, Mainster KJ. Nd:YAG Laser Photodisruptors.Ophthalmology1983, 90(9).

  20. Mainster MA, Sliney DH, Belcher CD, Buzney SM. Laser photodisruptors. Ophthalmology. 1983;90(8):973–91.

    Article  CAS  PubMed  Google Scholar 

  21. Puliafito CA, Wasson PJ, Steinert RF, Gragoudas ES. Neodymium-YAG laser surgery on experimental vitreous membranes. Arch Ophthalmol. 1984;102(6):843–7.

    Article  CAS  PubMed  Google Scholar 

  22. Khadka D, Bhandari S, Bajimaya S, Thapa R, Paudyal G, Pradhan E. Nd:YAG laser hyaloidotomy in the management of Premacular Subhyaloid Hemorrhage. BMC Ophthalmol. 2016;16:41.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ulbig MW, Mangouritsas G, Rothbacher HH, Hamilton AM, McHugh JD. Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed nd:YAG laser. Arch Ophthalmol. 1998;116(11):1465–9.

    Article  CAS  PubMed  Google Scholar 

  24. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13(4):388–91.

    Article  CAS  PubMed  Google Scholar 

  25. Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test. Investig Ophthalmol Vis Sci. 2006;47(3):1236–40.

    Article  Google Scholar 

  26. Nadel AJ, Gupta KK. Macroaneurysms of the retinal arteries. Arch Ophthalmol. 1976;94(7):1092–6.

    Article  CAS  PubMed  Google Scholar 

  27. Chen Y-J, Kou H-K. Krypton laser membranotomy in the treatment of dense premacular hemorrhage. Can J Ophthalmol. 2004;39(7):761–6.

    Article  PubMed  Google Scholar 

  28. Sonmez K, Ozcan PY. Nd:YAG Laser Photodisruption for Multilevel Premacular Hemorrhage due to isolated retinal venous macroaneurysm. Case Rep Ophthalmol Med. 2017;2017:4630187.

    PubMed  PubMed Central  Google Scholar 

  29. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. The Lancet. 2010;376(9735):124–36.

    Article  Google Scholar 

  30. Ohlhausen M, Payne C, Greenlee T, Chen AX, Conti T, Singh RP. Impact and characterization of delayed Pan-Retinal Photocoagulation in proliferative Diabetic Retinopathy. Am J Ophthalmol. 2021;223:267–74.

    Article  PubMed  Google Scholar 

  31. Little HL, Jack RL. Q-switched neodymium: YAG laser surgery of the vitreous. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 1986, 224(3):240–246.

  32. Messmer EM, Heidenkummer HP, Kampik A. Ultrastructure of epiretinal membranes associated with macular holes. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 1998;236(4):248–54.

    Article  CAS  PubMed  Google Scholar 

  33. Faulborn J, Dunker S, Bowald S. Diabetic vitreopathy–findings using the celloidin embedding technique. Ophthalmol J Int d’ophtalmologie Int J Ophthalmol Z fur Augenheilkunde. 1998;212(6):369–76.

    Article  CAS  Google Scholar 

  34. Muqit MM, Stanga PE. Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane. Br J Ophthalmol. 2014;98(7):994–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Supported by the Zhejiang Provincial Natural Science Foundation of China (LY22H120004, LQ20H120010).

Author information

Author notes

  1. Zhaoan Su and Luyao Tong contributed equally to this work.

Authors and Affiliations

  1. Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China

    Zhaoan Su, Luyao Tong, Jingliang He, Lijuan Wang, Jun Liu, Xiaoyun Fang & Li Zhang

  2. Department of Ophthalmology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315000, China

    Luyao Tong

Authors
  1. Zhaoan Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luyao Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jingliang He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lijuan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaoyun Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors conceived and designed the study protocol. JH and JL provided patient care. ZS performed the laser. LT and LW collected the data. LT was involved in the analysis and wrote the first draft of the manuscript. ZS, XF and LZ reviewed and revised the manuscript and produced the final version. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Li Zhang.

Ethics declarations

Ethics approval and consent to participate

This study has been approved by the Institutional Review Board of the Second Affiliated Hospital, School of Medicine, Zhejiang University in Hangzhou, China. All patients provided written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not Applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Su, Z., Tong, L., He, J. et al. Evaluation of a new Q-switched Nd:YAG laser on premacular hemorrhage. BMC Ophthalmol 23, 146 (2023). https://doi.org/10.1186/s12886-023-02876-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-023-02876-7

Keywords

BMC Ophthalmology

ISSN: 1471-2415

Contact us